157 related articles for article (PubMed ID: 2171759)
1. Elimination of small cell carcinoma of the lung from human bone marrow by monoclonal antibodies and immunomagnetic beads.
Vredenburgh JJ; Ball ED
Cancer Res; 1990 Nov; 50(22):7216-20. PubMed ID: 2171759
[TBL] [Abstract][Full Text] [Related]
2. Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads.
Vredenburgh JJ; Simpson W; Memoli VA; Ball ED
Cancer Res; 1991 May; 51(9):2451-5. PubMed ID: 1673088
[TBL] [Abstract][Full Text] [Related]
3. Purging of small cell lung cancer cells from bone marrow using immunomagnetic beads and a flow-through device.
Ball ED; Powers FJ; Vredenburgh JJ; Heath CA; Converse AO
Bone Marrow Transplant; 1991 Jul; 8(1):35-40. PubMed ID: 1655139
[TBL] [Abstract][Full Text] [Related]
4. Expression of antigens associated with small cell carcinoma of the lung on hematopoietic progenitor cells.
Ball ED; Keefe KA; Colby E
Cancer Res; 1987 Dec; 47(24 Pt 1):6556-9. PubMed ID: 2824035
[TBL] [Abstract][Full Text] [Related]
5. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies and magnetic microspheres for the depletion of leukaemic cells from bone marrow harvested for autologous transplantation.
Kemshead JT; Treleaven J; Heath L; Meara AO; Gee A; Ugelstad J
Bone Marrow Transplant; 1987 Aug; 2(2):133-9. PubMed ID: 3332162
[TBL] [Abstract][Full Text] [Related]
7. Isolation of hemopoietic precursor cells from human marrow by negative selection using monoclonal antibodies and immunomagnetic beads.
Cottler-Fox M; Bazar LS; Deeg HJ
Prog Clin Biol Res; 1990; 333():277-84. PubMed ID: 2308986
[TBL] [Abstract][Full Text] [Related]
8. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
9. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies.
De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A
Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of a modified immunomagnetic procedure for the purging of neuroblastoma cells from bone marrow].
Kremens B; Combaret V; Favrot MC; Laurent JC; Philip T
Monatsschr Kinderheilkd; 1990 Jun; 138(6):331-6. PubMed ID: 2197550
[TBL] [Abstract][Full Text] [Related]
11. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads.
Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C
Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147
[TBL] [Abstract][Full Text] [Related]
12. Influence of single and double immunomagnetic depletion on the hemopoietic capacity of marrow in patients with advanced neuroblastoma submitted to autologous bone marrow transplantation.
Lopez M; Zucker JM; Urresola R; Douay L; Quintana E; Kemshead J; Gorin NC; Vilcoq JR
Bone Marrow Transplant; 1987 Dec; 2(4):413-9. PubMed ID: 3332188
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer cells are effectively purged from peripheral blood progenitor cells with an immunomagnetic technique.
Tyer CL; Vredenburgh JJ; Heimer M; Peters WP; Bast RC
Clin Cancer Res; 1996 Jan; 2(1):81-6. PubMed ID: 9816094
[TBL] [Abstract][Full Text] [Related]
14. Effective removal of SCLC cells from human bone marrow. Use of four monoclonal antibodies and immunomagnetic beads.
Myklebust AT; Pharo A; Fodstad O
Br J Cancer; 1993 Jun; 67(6):1331-6. PubMed ID: 8390285
[TBL] [Abstract][Full Text] [Related]
15. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
Elias AD; Pap SA; Bernal SD
Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
[TBL] [Abstract][Full Text] [Related]
16. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC
Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144
[TBL] [Abstract][Full Text] [Related]
17. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation.
Shpall EJ; Bast RC; Joines WT; Jones RB; Anderson I; Johnston C; Eggleston S; Tepperberg M; Edwards S; Peters WP
Bone Marrow Transplant; 1991 Feb; 7(2):145-51. PubMed ID: 2049558
[TBL] [Abstract][Full Text] [Related]
18. S-L 11.14: a monoclonal antibody recognizing neuroectodermal tumors with possible value for bone marrow purging before autograft.
Combaret V; Kremens B; Favrot MC; Laurent JC; Philip T
Bone Marrow Transplant; 1988 May; 3(3):221-7. PubMed ID: 2844344
[TBL] [Abstract][Full Text] [Related]
19. Fractionation of normal and beta-thalassemic human hemopoietic progenitor cells by immunomagnetic beads.
Kannourakis G; Bol S
Exp Hematol; 1987 Dec; 15(11):1103-8. PubMed ID: 3678411
[TBL] [Abstract][Full Text] [Related]
20. The effect of recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor on Fc gamma receptor expression and antibody-dependent cellular cytotoxicity of hematopoietic progenitor cells during in vitro myeloid maturation.
Ericson SG; Benoit NE; Mills LE; Fanger MW
Exp Hematol; 1994 Mar; 22(3):283-9. PubMed ID: 7509291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]